Moffitt Partners with IBA for Proton Therapy
Moffitt Cancer Center is excited to announce its partnership with IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, to bring proton therapy to our patients.
As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt is adding IBA’s Proteus®ONE compact proton therapy system as part of our ongoing expansion.
Proton therapy is used to treat a growing number of cancers throughout the body, but it is especially impactful when treating areas where cancerous lesions are close to other vital structures. Using protons minimizes damage to healthy tissue surrounding a cancerous lesion, impacting only the targeted area.
This new technology will allow us to expand our clinical and research expertise into proton therapy and continue to provide the best possible patient outcomes. We expect the proton therapy center to be a vital resource, not just for the Tampa Bay community, but throughout the state of Florida and beyond.
We expect to treat patients as early as 2026. To learn more about the IBA’s Proteus®ONE compact proton therapy system, watch the video below.
If you'd like to refer a patient to Moffitt Cancer Center, complete our online form or contact a physician liaison for assistance. As part of our efforts to shorten referral times as much as possible, online referrals are typically responded to within 24 - 48 hours.